Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size

被引:20
作者
Fay, Michael P.
Halloran, M. Elizabeth
Follmann, Dean A.
机构
[1] NIAID, Bethesda, MD 20892 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Biostat & Biomath, Seattle, WA 98109 USA
[3] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA
关键词
binomial; compliance; normal; poisson; power; sample size;
D O I
10.1111/j.1541-0420.2006.00703.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We consider sample size calculations for testing differences in means between two samples and allowing for different variances in the two groups. Typically, the power functions depend on the sample size and a set of parameters assumed known, and the sample size needed to obtain a prespecified power is calculated. Here, we account for two sources of variability: we allow the sample size in the power function to be a stochastic variable, and we consider estimating the parameters from preliminary data. An example of the first source of variability is nonadherence (noncompliance). We assume that the proportion of subjects who will adhere to their treatment regimen is riot known before the study, but that the proportion is a stochastic variable with a known distribution. Under this assumption, we develop simple closed form sample size calculations based on asymptotic normality. The second source of variability is in parameter estimates that are estimated from prior data. For example, we account for variability in estimating the variance of the normal response from existing data which are assumed to have the same variance as the study for which we are calculating the sample size. We show that we can account for the variability of the variance estimate by simply using a slightly larger nominal power in the usual sample size calculation, which we call the calibrated power. We show that the calculation of the calibrated power depends only on the sample size of the existing data, and we give a table of calibrated power by sample size. Further, we consider the calculation of the sample size in the rarer situation where we account for the variability in estimating the standardized effect size from some existing data. This latter situation, as well as several of the previous ones, is motivated by sample size calculations for a Phase 11 trial of a malaria vaccine candidate.
引用
收藏
页码:465 / 474
页数:10
相关论文
共 19 条
[1]   Bayesian statistics and the efficiency and ethics of clinical trials [J].
Berry, DA .
STATISTICAL SCIENCE, 2004, 19 (01) :175-187
[2]  
Box GE., 2011, BAYESIAN INFERENCE S
[3]   A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials [J].
Brittain, E ;
Lin, D .
STATISTICS IN MEDICINE, 2005, 24 (01) :1-10
[4]  
Cohen J., 1988, POWERSTATISTICALSCIE, DOI 10.4324/9780203771587
[5]  
Fay MP, 1997, STAT MED, V16, P791
[6]  
FAY MP, 2005, 4 MULT IN MAL MIM PA
[7]   EQUIVALENCE OF WEIGHTED KAPPA AND INTRACLASS CORRELATION COEFFICIENT AS MEASURES OF RELIABILITY [J].
FLEISS, JL ;
COHEN, J .
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT, 1973, 33 (03) :613-619
[8]  
Ghosh BK, 1991, Handbook of Sequential Analysis
[9]  
Halloran ME, 1996, AM J EPIDEMIOL, V144, P83, DOI 10.1093/oxfordjournals.aje.a008858
[10]  
Jennison C, 1999, GROUP SEQUENTIAL MET